Poit. (Lamiaceae) commonly called curry leaf and savanna plant which is abundantly found in farmlands. Traditionally, the plant is used in the treatment of diabetes mellitus, fever, eczema, cancers and headache. The present study was aimed to investigate the in vitro antioxidant and antidiabetic potential of aerial parts of H. suaveolens Poit at dose levels of 250 and 500 mg/kg, in acute normoglycemic and alloxan induced hyperglycemic rats including oral glucose tolerance and chronic study (11 days), keeping glibenclamide (5 mg/kg) as standard drug. The body weight measurement and selective serum biochemical estimation (blood glucose concentration, ALT, AST, ALP, urea, creatinine, triglyceride, and cholesterol) were undertaken in 11 days treated hyperglycemic rats. The test result revealed that in normoglycemic rats, the decrease in blood glucose level lies between 4 to 15% in extract treated groups, while the hyperglycaemic rats showed a significant (p<0.05 to 0.001) fall of blood sugar level in a progressive manner and similar findings also observed in glucose tolerance test to an extent of p<0.05. The results of body weight and tested biochemical parameters of blood serum of the 11-days treated animals showed in favor of the anti diabetic activity of the test extracts. In DPPH scavenging anti-oxidant assay, the IC50 value of the test extracts were found as 30.06 and 28.76 μg/ml while the IC50 value of ascorbic acid was 20.92 μg/ml. This study suggests that the aerial part of H. suaveolens is endowed with antidiabetic and antioxidant potential.
INTRODUCTION
Diabetes mellitus (DM) is a syndrome which affects more and more people in all countries over the world. It is well known that diabetes mellitus is the commonest endocrine disorder that, according to the World Health Organization (WHO, 2004) , affects more than 176 million people worldwide. From an ethnopharmacological perspective, it is important to understand that this disease is one at the interface of conventional biomedical and local (or traditional) treatment. Diabetes mellitus (DM) which not only lead to hyperglycemia also cause many complications, such as hyperlipidemia, hypertension and artherosclerosis *Corresponding author. E-mail: praveen_nayak2000@yahoo. com, psnayak2000@gmail.com. Tel: +919926498776. (Bakırel et al., 2008; Sepici et al., 2004; Luo et al., 2004; Abdel-Barry et al., 1997) .
Many plant species are known in folk medicine of different cultures to be used for their hypoglycaemic properties and therefore used for treatment of DM (Abdel-Barry et al., 1997; Pushparaj et al., 2000) . Despite this, few traditionally used antidiabetic plants have received proper scientific screening.
The plant, H. suaveolens (L) Poit commonly known as W. tulsi belongs to the family Lamiaceae and is an ethnobotanically important medicinal plant. The plant has been considered as an obnoxious weed, distributed throughout the tropics and subtropics. Almost all parts of this plant are being used in traditional medicine to treat various diseases. The leaves of H. suaveolens have been utilized as a stimulant, carminative, sudorific, galactolgogue and as a cure for parasitic cutaneous diseases (Anonymous, 1964) .
Crude leaf extract is also used as a relief to colic and stomach ache. Leaves and twigs are considered to be antispasmodic and used in antirheumatic and antisudorific baths, anti-inflammatory, antifertility agents ( (Kirtikar and Basu, 1991) and also applied as an antiseptic in burns, wounds, and various skin complaints. The decoction of the roots is highly valued as appetizer and is reported to contain urosolic acid, a natural HIV-integrase inhibitor (Chatterjee and Pakrashi, 1997) .
Fumes of the dried leaves are also used to repel mosquitoes and control insect pests of stored grains. The leaves of the plant have been shown to contain alkaloids, terpenes and volatile oils (Gills, 1992) .
The present study has been designed to determine the role of extracts of aerial parts of H. suaveolens for in vitro antioxidant activity and potential antidiabetic activity if any, against normoglycemic and alloxan induced hyper glycemic rats.
MATERIALS AND METHODS
The plant material used in this study was aerial parts of H. suaveolens, collected from road side area from Khargone district Khargone M.P., India, during spring (mid-August to mid-October, 2010) and was authenticated by the Taxonomist Dr. S. K Mahajan, Botany Department, Government P G College Khargone M.P. The plant materials were initially rinsed with distilled water and dried on paper towel in laboratory at (37 ± 1°C) for 24 h and milled into coarse powder by a mechanical grinder.
Preparation of extract
The plant materials (1 kg) were initially defatted with petroleum ether and then extracted with alcohol and water using Soxhlet apparatus. The yield of the plant extracts ethanol (95%) and aqueous measured about 20 g each after evaporating the solvent using water bath. The standard extracts obtained were then stored in a refrigerator at 4°C for further use (Akueshi et al., 2002) .
Preparation of the test samples
Glibenclamide (5 mg/kg) was used as the reference control. The test extract was suspended in 25% Tween 20 in distilled water prior to oral administration to the experimental animals. Animals in the control group received only the 25% Tween 20 (2 ml/kg). All the test samples were administered through oral route.
Animals used
Male albino Wistar rats, weighing 150 to 200 g and Swiss albino mice, weighing 20 to 25 g were used. Prior to the experiments, the selected animals were housed in acrylic cages in standard environmental conditions (20 to 25°C), fed with standard rodent diet for 1 week in order to adapt to the laboratory conditions and water was given ad libitum. They were fasted overnight (12 h) before experiments, but were allowed free access to water. Six animals were used for each group of study. All the experiments on animals were conducted in accordance with the internationally accepted principles for laboratory animal use and as per the experimental protocols duly approved by the Institutional Ethical Committee (IAEC No. 1171/C/08/CPCSEA).
Determination of blood glucose levels
Fasting blood glucose concentration was determined using a blood Glucometer (Optimum), based on the glucose oxidase method. Blood samples were collected from the tip of tail at the defined time patterns (Aslan et al., 2007a; .
Screening for antidiabetic activity
The Screening for antidiabetic activity was followed as per standard procedures (Dash et al., 2001) . The test samples were suspended in 25% Tween 20 in distilled water. Glibenclamide (5 mg/kg) was used as reference control during the study. All the test samples were administered through oral route.
Single dose study

Normoglycaemic animals
The animals were fasted for 18 h, but were allowed free access to water before and throughout the duration of experiment. At the end of the fasting period, taken as zero time (0 h), blood was withdrawn (0.1 ml) from the tip of the tail of each rat under mild ether anaesthesia. Plasma was separated following centrifugation and the glucose was estimated by GOD/POD method using Glucose estimation kit from M/s. Sigma Diagnostics (India) Pvt. Ltd., Baroda, India. The normal rats were then divided into six groups of six animals each. Group I served as solvent control and received only vechicle (2 ml/kg) through oral route, Group II received glibenclamide (5 mg/kg) and served as reference control. Groups III to VI received the alcohol and aqueous extract at a dose of 250 and 500 mg/kg, respectively, through oral route. Blood glucose levels were examined after 1, 2, 4, 6, 8 and 10 h of administration of single dose of test and control samples (Table 1) .
Alloxan induced diabetic animals
The acclimatized animals were kept fasting for 24 h with water ad libitum and injected intraperitoneally a dose of 150 mg/kg of alloxan monohydrate in normal saline. After 1 h, the animals were provided feed ad libitum. The blood glucose level was checked before alloxanisation and 24 h after alloxanization as aforementioned. Animals were considered diabetic when the blood glucose level was raised beyond 250 mg/100 ml of blood. This condition was observed at the end of 72 h after alloxanisation. The animals were segregated into six groups of six rats in each. Group I served as normal reference, Group II served as solvent control and received vechicle (2 ml/kg) through oral route. Group III received glibenclamide (5 mg/kg). Groups IV to VII received the test extract at doses of 250 and 500 mg/kg in a similar manner as per the aforementioned experiment. Blood glucose level of each rat was estimated at 1, 2, 4, 6, 8 and 10 h, respectively (Table 2) .
Effect on oral glucose tolerance in rats
An oral glucose tolerance test (OGTT) was performed on diabetic highly significant as compare to normal control group. p< 0.05 *significant, **very significant, ***highly significant as compare to diabetic control group. (One way analysis of variance (ANOVA) followed by Dunnett's t-test). rats by feeding glucose (5 g/kg) per os. Animals were deprived of food 18 h before and during the experiment but were allowed free access to water. They were divided into 6 groups of 6 rats each. Four groups received the plant extract at the doses as per the aforementioned experiment by os. One group received 5 mg/kg of glibenclamide and the control group received the vehicle. The plant extract, glibenclamide and vehicle were orally administered 1 h before glucose administration. Blood glucose level was determined before drug and glucose administration (−1 and 0 h, respectively) and subsequently at 0.5, 1, 2 and 3 h after ( Table 3) .
Study of blood glucose level on alloxan induced 11days treated diabetic animals
The animals were kept fasting for 24 h with water ad libitum and injected alloxan monohydrate intraperitoneally at a dose of 150 mg/kg in normal saline. After 1 h, the animals were provided rodent-feed ad libitum. The blood glucose level was measured 72 h after administration of alloxan. The animals showing blood glucose level beyond 250 mg/dl were considered for the study. The diabetic animals were segregated into six groups of six rats each. Group II served as solvent control and received only vehicle (2 ml/kg) through oral route. Group III received glibenclamide (5 mg/kg). Groups IV and V received ethanol extract at doses of 250 and 500 mg/kg. Similarly, Groups VI and VII received aqueous extract at same dose level respectively in a similar manner for 11days. The Group I served as a normal reference. The blood glucose level was measured on 0, 3, 7 and 11 th day of treatment (Table 4) .
Determination of body weight and serum biochemical of 11-days treated alloxan induced diabetic rats
The body weight of the 11-days treated animals comprised of similar group distribution as earlier mentioned and was determined by simple weighing, using standard balance on 0, 3, 7 and 11 day of the study. The animals were sacrificed at the end of the study and blood samples were collected by standard method for estimation of serum urea, creatinine, triglycerides, AST, ALT, ALP and cholesterol (Tables 5 and 6 ).
In vitro antioxidant activity
DPPH radical scavenging activity
Quantitative analysis
The free radical scavenging capacity of the both extract was determined using DPPH. An ethanolic DPPH solution (0.004%) was mixed with serial dilutions (10 to 100 μg/ml) of crude extracts and after 30 min, the absorbance was read at 515 nm using a spectrophotometer (Schimadzu 1700 UVvisible spectrophotometer). Ascorbic acid was used as reference. The inhibition curve was plotted and IC 50 values obtained by Probit analysis (Viturro et al., 
1999).
Phytochemical Screening
Phytochemical screening of the prepared extracts was conducted with various qualitative tests to identify the presence of chemical constituents. To perform the tests, the following chemicals and reagents were used: steroids with chloroform and sulphuric acid, tannins with ferric chloride solution, gum with Molish reagents and concentrated sulfuric acid, flavonoids with Mg and HCl and saponins with the capability of producing suds. Alkaloids were tested with Mayer's reagent, Hager's reagent and Dagendorff's reagent. These were identified by characteristic color changes using standard procedures (Ghani, 2003) .
Statistical analysis
The data obtained in the animal experiments like body weight, fasting blood sugar and biochemical estimations were subjected to statistical analysis. All values are expressed as Mean ± SEM (Standard Error of Mean). The data were assessed by the analysis of variance (ANOVA). Mean values were considered significantly different if P< 0.05 and 0.001.
RESULTS AND DISCUSSION
Alloxan-induced type 2 diabetes is a chemical model of experimental diabetes mellitus developing a severe hyperglycaemia and widely used in the diabetic studies. This model was used in our investigation to evaluate the effects of aerial parts of H. suaveolens ethanolic and aqueous extracts on hyperglycaemia and some metabolic disorders related to diabetic mellitus. The effects of ethanol and aqueous extracts of aerial parts of H. suaveolens on fasting blood glucose levels of normal and diabetic rats are presented in Tables 1 and 2 respectively. The plant extracts induced 4 to 15% fall of fasting blood glucose which is not significant enough to interpret hypoglycemic effect on normal rats (Table 1) . Treatment of normal rats with glibenclamide produced a significant (p<0.01) hypoglycaemic effect from first to 6 h, reaching a 41.15% maximum fall (p<0.01) in the blood glucose, as compared with the normal control group or with time 0. In alloxan induced diabetic rats as shown in Table 2 , a dose dependent effect of the plant extract was observed. The test extracts showed a persistent decrease in blood glucose level till the end of 10 h, with maximal decrease noted in aqueous extract at 500 mg/kg dose, reaching 66.72% (p<0.01), while the standard drug glibenclamide showed 70.67% decrease. The test result presented in Table 3 , indicates that the test extracts induce reduction in hyperglycaemia during the glucose tolerance test in diabetic rats. The alloxan-induced hyper glycaemia was significantly (p<0.01) corrected by the plant extract at the end of the treatment (11 days) in a sustained dose dependent manner, the result of which is presented in table 4. The maximal reduction 63.10% was observed with aqueous extract at high dose of 500 mg/kg. The potency of the extract in the light of fall of blood sugar level is dose dependent and in the order of aqueous extract followed by ethanol extract. H. suaveolens recover the body weight of treated diabetic group in a significant extent (p<0.01) when compared with diabetic control group and approach towards the untreated control normal animal group (Table 5) .
The biochemical parameters of plasma urea, creatinine, triglyceride, cholesterol, AST, ALT, ALP values of treated diabetic groups at the end of the treatment (11 days) decreases in a significant extent (p<0.001) when compared with diabetic control group (Table 6 ). The extent of decrease is in a dose dependent order and the potency rest first with aqueous extract followed by ethanolic extract.
The preliminary phytochemical investigation report indicates that the aqueous extract of Hyptis suaveolens found to contain carbohydrates, saponins, tannins, alkaloids, flavonoids, terpenoids, steroids and sterols as Table 7) . From the results, it may be postulated that both the plant extracts have hydrogen donors thus, scavenging the free radical DPPH. It is generally accepted that alloxan treatment causes permanent destruction of β-cells and impairment of renal function and sulfonyl ureas are known to lower the blood glucose level by stimulating β-cells to release insulin (Pari and Maheswari, 1999) . The hypoglycemic effect comparable to glibenclamide suggested that the extract may act by regenerating the β-cells in alloxan-induced diabetes (Ghosh and Suryawanshi, 2001 ) and the decreased activity in glucose level in OGTT might be due to a decrease in the rate of initial glucose absorption when plant fiber is given orally with glucose (Day et al., 1990) . Diabetes mellitus results from the failure to use glucose for energy, which leads to increased utilization and decrease storage of protein respon-sible for reduction of body weight essentially by depletion of body proteins (Guyton and Hall, 2000) . It has been reported that the increase in glycaemia in alloxan or streptozotocininduced diabetic rats was associated with dislipidoemia charac-terized by elevated serum triglycerides total cholesterol levels (Dhanbal et al., 2006) . The improvement of blood glucose level induced by most hypoglycaemic treatment is associated with a reduction of serum triglycerides and total cholesterol. The presence of alkaloids, carbohy-drates, flavonoids, tannins, steroids and/or terpenes in the whole plant of H. suaveolens either as single constituents or in combination may be responsible for the observed anti-diabetic activity.
Conclusion
In this study, several animal models and in vitro assay were applied to evaluate the antidiabetic activity of ethanolic and aqueous extract of aerial parts of H. suaveolens Poit. As a conclusion, it could be speculated that the observed antidiabetic activity of H. suaveolens Poit might be related to the presence of tannins, terpenoids, steroids and flavonoid contents and having the potential to impart beneficial therapeutic effect in diabetes.
This study also establishes a correlation between antidiabetic and antioxidant potential and may be of considerable interest in preventing the ill effects of diabetes and oxidative stress in vivo. However, the plant extracts should be investigated to find out the chemical compounds responsible for antidiabetic action. Furthermore, in vitro antioxidant activity should be evaluated by other antioxidant methods, for example, nitric oxide scavenging activity, reducing power, lipid peroxidation assay.
